Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : JMAR Technologies(JMAR) -- Ignore unavailable to you. Want to Upgrade?

To: Starlight who wrote (7829)	4/21/1999 7:01:00 PM
From: Bilberry	Read Replies (1) \| Respond to of 9695

I agree also that there is manipulation going on. Since July there has been great news on JMAR, starting with the $13 million Darpa funding. Stock does not reflect this. The latest news is the best I have ever heard from JMAR, and it is trying to move up, and someone is trying to make it look weak. I have a question for anyone that might know. What kind of sales can JMAR get out of replacing the synchrotron with their x-ray source? I assume that 2000 will be the year that these are sold in quantity. Lets say they sold 20-30 units at 2-3 million each and 50% gross profit. That would be somewhere between $1 to $2 dollars per share earnings just from X-ray source sales. Its important that we get a handle on the potential here. Certainly it is a far bigger market than what we originally thought, since its not just x-ray lithography that can use the x-ray source. Now its medical uses and Universities. Something tells me that this announcement will have legs. Don't be surprised to see this written up in the NY Times Science section, or Scientific American. --Bilberry